Compare INKT & AERT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | INKT | AERT |
|---|---|---|
| Founded | 2017 | 2012 |
| Country | United States | Singapore |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Professional Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 59.4M | 39.7M |
| IPO Year | 2021 | 2021 |
| Metric | INKT | AERT |
|---|---|---|
| Price | $12.25 | $6.85 |
| Analyst Decision | Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $35.00 | N/A |
| AVG Volume (30 Days) | 11.5K | ★ 16.1K |
| Earning Date | 05-15-2026 | 02-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 110.87 |
| EPS | N/A | ★ 0.27 |
| Revenue | N/A | ★ $70,014,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $26.22 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $8.48 | $0.26 |
| 52 Week High | $16.30 | $7.65 |
| Indicator | INKT | AERT |
|---|---|---|
| Relative Strength Index (RSI) | 60.47 | 48.53 |
| Support Level | $10.82 | $6.53 |
| Resistance Level | $12.74 | $7.30 |
| Average True Range (ATR) | 0.54 | 0.32 |
| MACD | 0.04 | -0.03 |
| Stochastic Oscillator | 84.76 | 26.79 |
MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering the discovery, development and manufacturing of allogeneic, off-the-shelf, invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases. iNKT cells offer distinct therapeutic advantages as a platform for allogeneic therapy in that the cells naturally home to tissues, aid clearance of tumors and infected cells, and suppress graft-versus-host-disease. Its product candidate, agenT-797, is an off-the-shelf, allogeneic, native iNKT cell therapy. It operates its business in single segment.
Aeries Technology Inc is a professional and management services partner offering a range of management consultancy services for private equity sponsors and their portfolio companies with engagement models that are designed to provide a mix of deep vertical specialty, functional expertise, and digital systems and solutions to scale, optimize and transform a client's business operations. It supports and drives its client's growth across the globe by providing a range of management consultancy services involving professional advisory services and operations management services to build and manage dedicated delivery centers in appropriate locations based on customer business needs. It has more than 40 clients spanning across industry segments.